MYGN - Myriad Genetics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2020)Next Year (2021)
No. of Analysts7888
Avg. Estimate0.310.31.061.4
Low Estimate0.30.2611.16
High Estimate0.310.351.181.65
Year Ago EPS0.380.461.671.06
Revenue EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2020)Next Year (2021)
No. of Analysts8899
Avg. Estimate209.81M201.22M807.31M851.8M
Low Estimate203.95M198.8M800.85M835.67M
High Estimate212M204.4M811.98M886M
Year Ago SalesN/AN/A851.1M807.31M
Sales Growth (year/est)N/AN/A-5.10%5.50%
Earnings History12/30/20183/30/20196/29/20199/29/2019
EPS Est.0.390.420.470.32
EPS Actual0.380.460.410.08
Difference-0.010.04-0.06-0.24
Surprise %-2.60%9.50%-12.80%-75.00%
EPS TrendCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2020)Next Year (2021)
Current Estimate0.310.31.061.4
7 Days Ago0.310.31.051.39
30 Days Ago0.310.31.051.39
60 Days Ago0.310.31.051.39
90 Days Ago0.480.481.822.05
EPS RevisionsCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2020)Next Year (2021)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days1N/A11
Growth EstimatesMYGNIndustrySectorS&P 500
Current Qtr.-18.40%N/AN/A0.01
Next Qtr.-34.80%N/AN/A0.06
Current Year-36.50%N/AN/A-0.02
Next Year32.10%N/AN/A0.14
Next 5 Years (per annum)5.25%N/AN/A0.08
Past 5 Years (per annum)-6.20%N/AN/AN/A